Revenue Breakdown
Composition ()
No data
Revenue Streams
Talphera Inc (TLPH) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is DSUVIA, accounting for 88.9% of total sales, equivalent to $224.00K. Another important revenue stream is DZUVEO. Understanding this composition is critical for investors evaluating how TLPH navigates market cycles within the Pharmaceuticals industry.
Profitability & Margins
Evaluating the bottom line, Talphera Inc maintains a gross margin of 100.00%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -342200.00%, while the net margin is -443600.00%. These profitability ratios, combined with a Return on Equity (ROE) of -86.48%, provide a clear picture of how effectively TLPH converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, TLPH competes directly with industry leaders such as ALGS and VERU. With a market capitalization of $42.50M, it holds a significant position in the sector. When comparing efficiency, TLPH's gross margin of 100.00% stands against ALGS's 100.00% and VERU's N/A. Such benchmarking helps identify whether Talphera Inc is trading at a premium or discount relative to its financial performance.
